Check out our executive chairman Lou on Cheddar News Friday:?Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market. https://lnkd.in/exRFc5zt
Vaxxinity
生物技术研究
Cape Canaveral，Florida 5,170 位关注者
Our mission is to democratize health by pioneering the third biologic revolution
关于我们
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
- 网站
-
https://www.vaxxinity.com
Vaxxinity的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Cape Canaveral，Florida
- 类型
- 私人持股
地点
-
主要
获取路线
505 Odyssey Way, Exploration Park
US，Florida，Cape Canaveral，32953
Vaxxinity员工
-
Derek Collison
Founder & CEO at Synadia. Creator of NATS.io
-
Peter H. Diamandis
Peter H. Diamandis是领英影响力人物 Data-driven optimist inspiring entrepreneurs through research, investment & community to create an abundant future for humanity | M.D. | Futurist |…
-
Jason Pesile MBA, CPA
Pharma / Biotech Finance Executive
-
Manal Morsy, MD, PhD, MBA
Chief Regulatory Officer, Head of Global Regulatory Affairs